Reporter Seungjae Lee
Contact: eccthomas@mdtoday.co.kr | 2023-11-27 19:01:37
A breakthrough in diagnostic technology has led to the development of a portable wireless device capable of detecting Alzheimer’s disease and Parkinson’s disease. The research findings have been detailed in the ‘Biophysics and Computational Biology’ journal, marking a significant step forward in the field of neurodegenerative disease diagnosis.
According to the report, the United States is currently home to more than 6.7 million individuals affected by Alzheimer’s disease. However, this number is projected to rise to 13.8 million by 2060 without the development of an effective treatment strategy. Unfortunately, progress in finding a cure for neurodegenerative diseases has been slow, largely due to the difficulties in designing clinical trials to test the effectiveness of potential treatments. Therefore, early detection and diagnosis are critical in addressing these conditions.
Researchers at the University of California, San Diego, have successfully designed a wireless portable device specifically tailored to diagnose Alzheimer’s disease and Parkinson’s disease. Originally developed to detect the SARS-CoV-2 virus, which causes COVID-19, the device utilizes short nucleic acid strands to target only specific molecules, delivering promising results in previous studies for detecting mutated viruses, even in trace amounts.
The device was put to the test using brain cells obtained from autopsies of deceased elderly patients, and the results were remarkable. Not only did it successfully identify key proteins associated with Alzheimer’s and Parkinson’s diseases, but it also demonstrated the capability to detect and concentrate on these specific markers.
As a result of this groundbreaking research, it is concluded that this newly developed wireless portable device holds great promise for the diagnosis of Alzheimer’s disease and Parkinson’s disease, providing hope for improved early detection and intervention strategies.
[ⓒ Medical Today. All rights reserved. Redistribution of this content is prohibited.]
Most Viewed Articles
Warning: illegal string offset ‘txid’ at /home/mdtoday/mobile_html/_libs/function.lib.news.160503.php line 1633
Warning: illegal string ‘limit’ set at /home/mdtoday/mobile_html/_libs/function.lib.news.160503.php line 1670
Registration Number: Seoul A00177 | Registration Date: 2006-02-23
Publisher: Sangwon Kim | Editor: Shin Hyeon-jeong
7th Floor, Seosong Tower, 86-6 Sadang-dong, Dongjak-gu, Seoul
Main Telephone Number: 02-561-4494
Email: mdtoday@mdtoday.co.kr
© Medical Today ALL RIGHTS RESERVED.
Reporter Seungjae Lee
eccthomas@mdtoday.co.kr | 2023-11-27 19:01:37
▲ A portable wireless device capable of diagnosing Alzheimer’s disease and Parkinson’s disease has been developed. (Photo = DB)
[메디컬투데이=이승재 기자] A portable wireless device capable of diagnosing Alzheimer’s disease and Parkinson’s disease has been developed.
Research results on a portable wireless device that can diagnose Alzheimer’s disease and Parkinson’s disease have been published in the journal ‘Biophysics and Computational Biology.’
There are more than 6.7 million people with Alzheimer’s disease in the United States, and unless an effective treatment is developed, this number is expected to increase to 13.8 million by 2060.
However, progress in treatment for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease is slow. This is because it is realistically difficult to design clinical trials to test the effectiveness of a drug. Therefore, it is important to detect and diagnose these neurodegenerative diseases early.
Researchers at the University of California, San Diego, USA, have developed a wireless portable device that can diagnose Alzheimer’s disease and Parkinson’s disease. The device was originally developed to detect SARS-CoV-2, the virus that causes COVID-19, and was designed to bind only to specific molecules using short strands of nucleic acid.
Previous research has shown that the device can detect mutated viruses even when the virus is present in very small amounts.
Using brain cells obtained from autopsies of deceased elderly patients, the researchers investigated whether the device could detect markers typically found in Alzheimer’s disease and Parkinson’s disease.
As a result of the study, the device reduced ‘beta-amyloid’ and ‘tau’, proteins characteristic of Alzheimer’s disease, and ‘alpha-synuclein’, a protein characteristic of Parkinson’s disease. It was also to detect while concentrating.
The researchers concluded that the newly developed wireless portable device could be used to diagnose Alzheimer’s disease and Parkinson’s disease.
[ⓒ 메디컬투데이. 무단전재-재배포 금지]
Most viewed articles
Warning: illegal string offset ‘txid’ in /home/mdtoday/mobile_html/_libs/function.lib.news.160503.php online 1633
Warning: illegal string ‘limit’ set in /home/mdtoday/mobile_html/_libs/function.lib.news.160503.php online 1670
Registration number: Seoul A00177 | Registration date: 2006-02-23
Publisher: Sangwon Kim | Editor: Shin Hyeon-jeong
7th floor, Seosong Tower, 86-6 Sadang-dong, Dongjak-gu, Seoul
Main telephone number: 02-561-4494
email: mdtoday@mdtoday.co.kr
© Medical Today ALL RIGHTS RESERVED.
#Development #portable #wireless #device #diagnose #Alzheimers #disease #Parkinsons #disease
